Other Species / Isoforms
  JunB (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K4-sm
____MCTkMEQPFYH
0 1
JunB (human) ____MCTkMEQPFYH K4-sm
JunB (mouse) ____MCTKMEQPFYH K4
JunB (rat) ____MCTKMEQPFYH K4
A23
TATGYGRAPGGLSLH
1 7
JunB (human) TATGYGRAPGGLSLH A23
JunB (mouse) AAAGYGRsPGSLSLH S23-p
JunB (rat) AAAGYGRsPGSLSLH S23-p
K33-sm
GLSLHDYkLLkPSLA
0 1
JunB (human) GLSLHDYkLLkPSLA K33-sm
JunB (mouse) SLSLHDYKLLKPTLA K33
JunB (rat) SLSLHDYKLLKPTLA K33
K36-ac
LHDYkLLkPSLAVNL
0 1
JunB (human) LHDYkLLkPSLAVNL K36-ac
JunB (mouse) LHDYKLLKPTLALNL K36
JunB (rat) LHDYKLLKPTLALNL K36
K36-ub
LHDYkLLkPSLAVNL
0 2
JunB (human) LHDYkLLkPSLAVNL K36-ub
JunB (mouse) LHDYKLLKPTLALNL K36
JunB (rat) LHDYKLLKPTLALNL K36
K36-sm
LHDYkLLkPSLAVNL
0 1
JunB (human) LHDYkLLkPSLAVNL K36-sm
JunB (mouse) LHDYKLLKPTLALNL K36
JunB (rat) LHDYKLLKPTLALNL K36
Y47-p
AVNLADPyRsLkAPG
1 5
JunB (human) AVNLADPyRsLkAPG Y47-p
JunB (mouse) ALNLADPYRGLKGPG Y47
JunB (rat) ALNLADPYRGLKGPG Y47
S49-p
NLADPyRsLkAPGAR
0 1
JunB (human) NLADPyRsLkAPGAR S49-p
JunB (mouse) NLADPYRGLKGPGAR G49
JunB (rat) NLADPYRGLKGPGAR G49
K51-sm
ADPyRsLkAPGARGP
0 1
JunB (human) ADPyRsLkAPGARGP K51-sm
JunB (mouse) ADPYRGLKGPGARGP K51
JunB (rat) ADPYRGLKGPGARGP K51
Y68-p
EGGGGGSyFSGQGSD
0 2
JunB (human) EGGGGGSyFSGQGSD Y68-p
JunB (mouse) EGSGAGSYFSGQGSD Y68
JunB (rat) EGSGAGSYFSGQGSD Y68
S79-p
QGSDTGAsLKLASSE
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • transcription, altered
Treatment
  • 2-deoxyglucose
  • SB203580
JunB (human) QGSDTGAsLKLASSE S79-p
JunB (mouse) QGSDTGASLKLASTE S79
JunB (rat) QGSDTGASLKLASTE S79
T100
PNSNGVITTtPtPPG
0 1
JunB (human) PNSNGVITTtPtPPG T100
JunB (mouse) PNSNGVItttPtPPG T100-p
JunB (rat) PNSNGVITTTPTPPG T100
T101
NSNGVITTtPtPPGQ
0 1
JunB (human) NSNGVITTtPtPPGQ T101
JunB (mouse) NSNGVItttPtPPGQ T101-p
JunB (rat) NSNGVITTTPTPPGQ T101
T102-p
SNGVITTtPtPPGQy
Upstream
Downstream
1 4
JunB (human)
T102-p
JunB (mouse)
T102-p
JunB (rat)
T102-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (mouse)
Treatment
  • ionomycin
  • nocodazole
  • phorbol_ester
JunB (human) SNGVITTtPtPPGQy T102-p
JunB (mouse) SNGVItttPtPPGQY T102-p
JunB (rat) SNGVITTTPTPPGQY T102
T104-p
GVITTtPtPPGQyFy
Upstream
Downstream
1 10
JunB (human)
T104-p
JunB (mouse)
T104-p
JunB (rat)
T104-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • JNK1 (human)
Putative in vivo kinases:
  • JNK1 (mouse)
Treatment
  • ionomycin
  • nocodazole
  • phorbol_ester
JunB (human) GVITTtPtPPGQyFy T104-p
JunB (mouse) GVItttPtPPGQYFY T104-p
JunB (rat) GVITTTPTPPGQYFY T104
Y109-p
tPtPPGQyFyPRGGG
1 4
JunB (human) tPtPPGQyFyPRGGG Y109-p
JunB (mouse) tPtPPGQYFYPRGGG Y109
JunB (rat) TPTPPGQYFYPRGGG Y109
Y111-p
tPPGQyFyPRGGGsG
0 2
JunB (human) tPPGQyFyPRGGGsG Y111-p
JunB (mouse) tPPGQYFYPRGGGSG Y111
JunB (rat) TPPGQYFYPRGGGSG Y111
S117-p
FyPRGGGsGGGAGGA
Upstream
0 7
Treatment
  • nocodazole
JunB (human) FyPRGGGsGGGAGGA S117-p
JunB (mouse) FYPRGGGSGGGTGGG S117
JunB (rat) FYPRGGGSGGGTGGG S117
T129-p
GGAGGGVtEEQEGFA
0 1
JunB (human) GGAGGGVtEEQEGFA T129-p
JunB (mouse) GGTGGGVTEEQEGFA T126
JunB (rat) GGTGGGVTEEQEGFA T126
T153
LHKMNHVTPPNVSLG
1 0
JunB (human) LHKMNHVTPPNVSLG T153
JunB (mouse) LHKMNHVTPPNVSLG T150
JunB (rat) LHKMNHVtPPNVSLG T150-p
Y173-p
PAGPGGVyAGPEPPP
Upstream
Downstream
1 1
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • Abl (human)
JunB (human) PAGPGGVyAGPEPPP Y173-p
JunB (mouse) QAGPGGVYAGPEPPP Y170
JunB (rat) QAGPGGVYAGPEPPP Y170
Y182-p
GPEPPPVyTNLSSyS
Upstream
Downstream
1 1
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • Abl (human)
JunB (human) GPEPPPVyTNLSSyS Y182-p
JunB (mouse) GPEPPPVYTNLSSYS Y179
JunB (rat) GPEPPPVYTNLSSYs Y179
Y188-p
VyTNLSSySPASASS
Upstream
Downstream
1 1
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • Abl (human)
JunB (human) VyTNLSSySPASASS Y188-p
JunB (mouse) VYTNLSSYSPASAPS Y185
JunB (rat) VYTNLSSYsPASAPS Y185
S189
yTNLSSySPASASSG
1 0
JunB (human) yTNLSSySPASASSG S189
JunB (mouse) YTNLSSYSPASAPSG S186
JunB (rat) YTNLSSYsPASAPSG S186-p
S237-p
LGLGRGAstFkEEPQ
0 2
JunB (human) LGLGRGAstFkEEPQ S237-p
JunB (mouse) LGLSRGAsAFkEEPQ S234-p
JunB (rat) LGLSRGASAFkEEPQ S234
T238-p
GLGRGAstFkEEPQT
0 1
JunB (human) GLGRGAstFkEEPQT T238-p
JunB (mouse) GLSRGAsAFkEEPQT A235
JunB (rat) GLSRGASAFkEEPQT A235
K240-ac
GRGAstFkEEPQTVP
0 3
JunB (human) GRGAstFkEEPQTVP K240-ac
JunB (mouse) SRGAsAFKEEPQTVP K237
JunB (rat) SRGASAFkEEPQTVP K237-ac
K240-ub
GRGAstFkEEPQTVP
0 1
JunB (human) GRGAstFkEEPQTVP K240-ub
JunB (mouse) SRGAsAFKEEPQTVP K237
JunB (rat) SRGASAFKEEPQTVP K237
K240-sm
GRGAstFkEEPQTVP
1 2
JunB (human) GRGAstFkEEPQTVP K240-sm
JunB (mouse) SRGAsAFkEEPQTVP K237-sm
JunB (rat) SRGASAFKEEPQTVP K237
S251-p
QTVPEARsRDAtPPV
Upstream
Downstream
1 44
Effects on Modified Protein
  • protein degradation
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • antibody
  • BI_4834
  • EGF
  • ionizing_radiation
  • selumetinib
  • vemurafenib
JunB (human) QTVPEARsRDAtPPV S251-p
JunB (mouse) QTVPEARsRDAtPPV S248-p
JunB (rat) QTVPEARSRDAtPPV S248
T255-p
EARsRDAtPPVsPIN
Upstream
Downstream
1 66
Effects on Modified Protein
  • protein degradation
Putative in vivo kinases:
  • GSK3B (human)
Regulatory protein:
  • TBK1 (human)
Treatment
  • antibody
  • lapatinib
  • selumetinib
  • vemurafenib
JunB (human) EARsRDAtPPVsPIN T255-p
JunB (mouse) EARsRDAtPPVsPIN T252-p
JunB (rat) EARSRDAtPPVsPIN T252-p
S259-p
RDAtPPVsPINMEDQ
Upstream
Downstream
4 73
Effects on Modified Protein
  • protein degradation
Regulatory protein:
  • TBK1 (human)
Treatment
  • 2-deoxyglucose
  • adriamycin
  • antibody
  • BI_4834
  • dasatinib
  • lapatinib
  • selumetinib
  • staurosporine
  • vemurafenib
  • Z-VAD-FMK
JunB (human) RDAtPPVsPINMEDQ S259-p
JunB (mouse) RDAtPPVsPINMEDQ S256-p
JunB (rat) RDAtPPVsPINMEDQ S256-p
K270
MEDQERIKVERKRLR
1 0
JunB (human) MEDQERIKVERKRLR K270
JunB (mouse) MEDQERIkVERKRLR K267-sm
JunB (rat) MEDQERIKVERKRLR K267
T302
RLEDKVKTLkAENAG
0 1
JunB (human) RLEDKVKTLkAENAG T302
JunB (mouse) RLEDKVKtLkAENAG T299-p
JunB (rat) RLEDKVKTLKAENAG T299
K304-ub
EDKVKTLkAENAGLS
0 1
JunB (human) EDKVKTLkAENAGLS K304-ub
JunB (mouse) EDKVKtLKAENAGLS K301
JunB (rat) EDKVKTLKAENAGLS K301
K304-sm
EDKVKTLkAENAGLS
1 1
JunB (human) EDKVKTLkAENAGLS K304-sm
JunB (mouse) EDKVKtLkAENAGLS K301-sm
JunB (rat) EDKVKTLKAENAGLS K301
S312-p
AENAGLSsTAGLLRE
0 1
JunB (human) AENAGLSsTAGLLRE S312-p
JunB (mouse) AENAGLSSAAGLLRE S309
JunB (rat) AENAGLSSAAGLLRE S309
K325-ub
REQVAQLkQKVMtHV
0 3
JunB (human) REQVAQLkQKVMtHV K325-ub
JunB (mouse) REQVAQLKQKVMTHV K322
JunB (rat) REQVAQLKQKVMTHV K322
T330-p
QLkQKVMtHVSNGCQ
0 1
JunB (human) QLkQKVMtHVSNGCQ T330-p
JunB (mouse) QLKQKVMTHVSNGCQ T327
JunB (rat) QLKQKVMTHVSNGCQ T327